Trial Details

UNKNOWN
Basic Information
Clinical ID c2630
Identifier NCT03185611
Trial Title Effectiveness of Rifaximin Combined With Thiopurine on Preventing Postoperative Recurrence in Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Crohn Disease
Interventions DRUG: Rifaximin|DRUG: Azathioprine
Participant Information
Sponsor Sixth Affiliated Hospital, Sun Yat-sen University
City Guangdong
Country/Region China
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2017-05-18
Primary Completion Date 2018-01-31
Completion Date 2018-07-31